DINO-VAMP

References

• 1998 . National Consensus Development Panel on Effective Treatment of Opiate Addiction . JAMA. , 280 : 1936 – 1943 .
   PubMed Web of Science ®Google Scholar
• 2000 . MMWR , 28 July 21 : 633 – 639 .
   Google Scholar
• National Household Survey on Drug Abuse . 1998 . Substance Abuse and Mental Health Services Administration , U.S. Department of Health and Human Resources .
   Google Scholar
• Galea , J. , Perez , J. and Watts , L. 1999 . Street Unit Studies Report. Drug Monitoring Program , New York State Office of Alcoholism and Substance Abuse Services .
   Google Scholar
• HIV/AIDS Surveillance Report. 9/25/92;13. U.S. Centers for Disease Control.
   Google Scholar
• Soft tissue infections among injections drug users-San Francisco, California 1996–2000 . MMWR. , 50 5/18/01
   Google Scholar
• Francis , H. 2003 . Substance abuse and HIV infection . Topics in HIV Medicine. , 11 Jan/Feb : 20 – 24 .
   PubMedGoogle Scholar
• Dole , V. P. and Nyswander , M. 1965 . A medical treatment for diacetylmorphine addiction-a clinical trail with methadone hydrochloride . JAMA. , 193 : 646 – 650 .
   PubMed Web of Science ®Google Scholar
• Strain , E. C. , Bigelow , G. E. , Liebson , I. A. and Stitzer , M. L. 1999 . Moderate vs. high dose metha-done in the treatment of opioid dependence: a randomized trial . JAMA. , 281 : 1000 – 1005 .
   PubMed Web of Science ®Google Scholar
• Delo , V. 1988 . Implications of methadone maintenance for treatment of narcotic addiction . JAMA. , 260 : 3021 – 3029 .
   PubMed Web of Science ®Google Scholar
• Maxwell , S. and Schinderman , M. 2002 . Optimizing long-term response to methadone maintenance treatment: a 152 week follow-up using higher dose methadone . Journal of Addictive Disease. , 21 : 1 – 11 .
   PubMed Web of Science ®Google Scholar
• Swan , N. Nov/Dec 1994 . NIDA (National Institute on Drug Use) Notes Nov/Dec , 19
   Google Scholar
• Ball , J. and Ross , A. 1993 . The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services and Outcome. , New York : Springer-Verlag Publications .
   Google Scholar
• Grahan , A. and Schultz , T. 1998 . Chapter 1 in Principles of Addiction Medicine, published by the American Society of Addiction Medicine. , Second Edition
   Google Scholar
• Payte , J. and Khouri , E. 1993 . “ Principles of methadone dose determination, Chapter 5 ” . In State Methadone Treatment Guidelines, Center for Substance Abuse Treatment Publications , Treatment Improvement Protocol Series. 1 U.S. Department of Health and Human Services . Substance Abuse and Mental Health Services Administration
   Google Scholar
• O’Connor , D. and Fiellin , D. 2001 . Pharmacologic treatment of heroin dependent patients . AIM. , 133 : 1724 – 1731 .
   Google Scholar
• Fiellin , D. D. , O’Connor , P. , Chawarski , M. , Pakes , J. , Pantalon , R. and Schottenfeld , R. 2001 . Methadone maintenance in primary care: a randomized controlled trial . JAMA. , 286 : 1724 – 1731 .
   PubMed Web of Science ®Google Scholar
• Novic , D. M. , Joseph , H. , Croxson , T. S. , Salsitz , E. , Wang , G. , Richman , B. , Poretsky , L. , Keefe , J. B. and Whimbey , E. 1990 . Absence of antibody to human immunodeficiency virus in long-term, sociallya rehabilitated methadone maintenance patients . ArchIntMed. , 150 : 97 – 99 .
   Google Scholar
• Maxwell , S. and Schinderman , M. 1999 . Optimizing response to methadone maintenance treatment: higher dose methadone . J Psychoactive Drugs. , 31 : 66 – 68 .
   Web of Science ®Google Scholar
• Marion , I. 2000 . Executive Director, Albert Einstein College of Medicine Division of Substance Abuse , Personal Communication
   Google Scholar
• Lesher , A. I. 1997 . Addiction is a brain disease and it matters . Science. , 278 : 45 – 47 .
   PubMed Web of Science ®Google Scholar
• Tashima , K. , Bose , T. , Gormley , J. , Sousa , H. and Flanagan , T. Miriam Hospital, Providence, RI. Abstract PO552 . The potential Impact of Efavirenz on Methadone Maintenance. 9th European Conference of Clinical Microbiology and Infectious Disease .
   Google Scholar
• Gourevitch , M. and Freidland , G. 2000 . Interactions between methadone and medications used to treat HIV infection: a review . The Mount Sinai Journal of Medicine. , 67 : 367 – 373 .
   Google Scholar
• Gourevitch , M. and Friedland , G. 1999 . Methadone and antiretroviral medications . AIDS Clinical Care. , 11 : 13 – 16 .
   Google Scholar
• O’Connor , P. , Carrol , K. , Shi , R. , Schottenfeld , R. , Kosten , B. and Rounsaville . 1997 . Opiate detoxification with buprenorphine or clonidine . AIM. , 127 : 526 – 530 .
   Google Scholar
• Leshner , A. 1998 . “ What We Know: Drug Addiction is a Brain Disease, Introduction to Second Addition ” . In Principles of Addiction Medicine, American Society of Addiction Medicine , Second Edition
   Google Scholar
• Brooner , R. , King , V. V. V. , Kidorf , M. , Schmidt , C. C. and Bigelow , G. E. 1997 . Psychiatric and substance abuse comorbidity among treatment seeking opiate abusers . Arch Gen Psychiatry. , 54 : 71 – 80 .
   PubMed Web of Science ®Google Scholar
• Maremanni , I. , Orietta , Z. , Agletti , M. , Marini , G. , Tagliamonte , A. , Schinderman , M. and Maxwell , S. 2000 . Methadone dose and retention during treatment of heroin addicts with axis 1 psychiatric comorbidity . Journal of Addictive Diseases. , 19 : 2234 – 2241 .
   Web of Science ®Google Scholar
• Herrlin , K. , Segerdahl , M. , Gustafsson , L. and Kalso , E. 2000 . Methadone, ciprofloxacin and adverse drug reactions . Lancet.l , 356 : 2069 – 2072 .
   PubMed Web of Science ®Google Scholar
• Nilson , P. 1982 . Effect of urinary acidity on the disposition of methadone in man . Eur J Clin Pharm. , 22 : 337 – 352 .
   PubMed Web of Science ®Google Scholar
• Leavitt , S. 2000 . Hepatitis C virus paradoxically increases methadone dose requirement . Addiction Treatment Forum. Fall , 9 : 6 – 9 .
   Google Scholar
• Silver , J. and Shaffer , H. 1996 . Change intolerance to shifts in methadone formulation: A preliminary investigation . Journal of Substance Abuse Treatment. , 113 : 331 – 339 .
   Google Scholar
• Gourevitch , M. , Hartell , D. , Tenore , P. , Freeman , K. , Marion , I. , Hecht , J. and Lowinson , J. 1999 . Three oral formulations of methadone: A clinical and pharmacodynamic comparison . Journal of Substance Abuse Treatment. , 17 : 237 – 241 .
   PubMed Web of Science ®Google Scholar
• Carr , B. and Wilson , J. Diseases of the Ovary and Female Reproductive Tract Chapter 340 in Harrison’s Principles of Internal Medicine, Isselbacheer, Braunwald, Wilson, Marine, Fausi, Kasper editors. 13th Edition. 1994
   Google Scholar
• Writing Group for the Woman’s Health Initiative Investigators. 2002 . Risks and benefits of estrogen plus progestin in healthy postmenopausal women . Principal results from the Women’s Health Initiative Randomized Controlled Trial. JAMA. , 288 : 321 – 333 .
   Google Scholar
• Kishan , P. 2000 . Oral clonidine in post menopausal patients . AIM. , 132 : 788 – 793 .
   Google Scholar
• Pond , S. , Kreek , M. , Tong , T. , Raghuanath , J. and Benowity , N. 1985 . Altered methadone pharmacokinetics in methadone maintained pregnant women . J Pharmacol Exp Therap. , 233 : 51 – 56 .
   PubMed Web of Science ®Google Scholar
• Jarvis , M. , Wupong , S. , Kniseley , J. and Schnoll , S. 1999 . Alterations in methadone metabolism during late pregnancy . Journal of Addictive Diseases. , 18 : 51 – 56 .
   PubMed Web of Science ®Google Scholar
• Miller , L. 1998 . “ Treaatment of the Addicted Woamn in Pregnancy, Section 16, Chapter 3 ” . In Principles of Addiction Medicine , Edited by: Grahan , A and Schultz , T . the American Society of Addiction Medicine . published by, Second Edition
   Google Scholar